Implantable or insertable medical device resistant to microbial growth and biofilm formation

• US 8,105,520 B2
• Filed: 01/21/2005
• Issued: 01/31/2012
• Est. Priority Date: 02/08/2002
• Status: Active Grant

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Miller, Kathleen M., Sydney, Gregory T., Geitz, Kurt, Dayton, Peter L., Sahatjian, Ronald A.
• Primary Examiner(s): Johnson, Christina
• Assistant Examiner(s): HUDA, SAEED M
• Application Number:
  US11/040,864
• Publication Number:
  US 20050161859A1
• Time in Patent Office: 2,566 Days
• Field of Search: 264/209.1, 264/176.1, 264/171.26, 264/171.27, 264/171.28, 264/211, 264/349, 604/508, 427/2.1, 427/2.3, D24/112
• US Class Current: 264/171.26
• CPC Class Codes: A61L 2/232 layered or coated
• CPC Class Codes: A61L 2300/202 with halogen atoms, e.g. triclosan, povidone-iodine
• CPC Class Codes: A61L 2300/206 Biguanides, e.g. chlorohexidine
• CPC Class Codes: A61L 2300/21 Acids
• CPC Class Codes: A61L 2300/404 Biocides, antimicrobial agents, antiseptic agents
• CPC Class Codes: A61L 2300/45 Mixtures of two or more drugs, e.g. synergistic mixtures
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
• CPC Class Codes: A61P 31/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
• CPC Class Codes: A61P 35/00 Antineoplastic agents
• CPC Class Codes: Y10T 428/1334 Nonself-supporting tubular film or bag [e.g., pouch, envelope, packet, etc.]
• CPC Class Codes: Y10T 428/1352 Polymer or resin containing [i.e., natural or synthetic]
• CPC Class Codes: Y10T 428/1372 Randomly noninterengaged or randomly contacting fibers, filaments, particles, or flakes
• CPC Class Codes: Y10T 428/1379 Contains vapor or gas barrier, polymer derived from vinyl chloride or vinylidene chloride, or polymer containing a vinyl alcohol unit
• CPC Class Codes: Y10T 428/1386 Natural or synthetic rubber or rubber-like compound containing
• CPC Class Codes: Y10T 428/1393 Multilayer [continuous layer]

Abstract

Disclosed are implantable or insertable medical devices that provide resistance to microbial growth on and in the environment of the device and resistance to microbial adhesion and biofilm formation on the device. In particular, the invention discloses implantable or insertable medical devices that comprise at least one biocompatible matrix polymer region, an antimicrobial agent for providing resistance to microbial growth and a microbial adhesion/biofilm synthesis inhibitor for inhibiting the attachment of microbes and the synthesis and accumulation of biofilm on the surface of the medical device. Also disclosed are methods of manufacturing such devices under conditions that substantially prevent preferential partitioning of any of said bioactive agents to a surface of the biocompatible matrix polymer and substantially prevent chemical modification of said bioactive agents.

Claims

1. A method of manufacturing an implantable or insertable medical device comprising:

providing a combination comprising;

(a) one or more biocompatible matrix polymers comprising an ethylene vinyl acetate copolymer and (b) bioactive agents comprising (i) triclosan as an antimicrobial agent and (ii) a microbial attachment/biofilm synthesis inhibitor selected from NSAIDS, chelating agents, and mixtures thereof;

processing said combination by mixing a polymer melt that comprises said combination under conditions that substantially prevent preferential partitioning of any of said bioactive agents to a surface of any of said biocompatible matrix polymers and that substantially prevent chemical reaction of said bioactive agents; and

shaping said combination into a matrix polymer region of an implantable or insertable medical device.

2. The method of claim 1, further comprising controlling either or both of the temperature and moisture content during said processing.

3. The method of claim 1, wherein said shaping comprises extrusion.

4. The method of claim 3, wherein said extrusion comprises forming at least one annular matrix polymer region.

5. The method of claim 4, further comprising forming at least one polymeric barrier layer at least partially covering a surface of said annular matrix polymer region.

6. The method of claim 5, wherein said method comprises a process selected from extrusion coating said polymeric barrier layer onto said annular matrix polymer region and solvent coating said polymeric barrier layer onto said annular matrix polymer region.

7. The method of claim 5, wherein said covering comprises coextruding said polymeric barrier layer and said annular matrix polymer region.

8. The method of claim 5, comprising forming a first polymeric barrier layer at least partially covering an interior surface of said annular matrix polymer region and forming a second polymeric barrier layer at least partially covering an exterior surface of said annular matrix polymer region.

9. The method of claim 8, wherein said covering comprises coextruding said first and second polymer barrier layers with said annular matrix polymer region.

10. The method of claim 9, wherein said first and second barrier layers comprise a material selected from the group consisting of ethylene vinyl acetate copolymers, copolymers of ethylene with acrylic acid or methacrylic acid, elastomeric polyurethanes and polyurethane copolymers, metallocene catalyzed polyethylene and polyethylene copolymers, ionomers, vinyl aromatic copolymers, silicones and mixtures thereof.

20. The method of claim 1, wherein said microbial attachment/biofilm synthesis inhibitor comprises salicylic acid or a salt thereof

21. The method of claim 20, wherein said combination comprises bismuth subcarbonate as a radio-opacifying agent.

22. The method of claim 1, wherein said mixing comprises applying mechanical shear to said one or more biocompatible matrix polymers and said one or more bioactive agents.

23. The method of claim 1, wherein said shaping comprises a process selected from molding, calendaring, and casting.

24. The method of claim 1, wherein said processing comprises mixing said polymer melt at a temperature ranging from about from about 70 °

C. to about 100 °

C.

25. The method of claim 24, wherein said bioactive agents comprise salicylic acid or a salt thereof as said microbial attachment/biofilm synthesis inhibitor.

26. The method of claim 25, wherein said polymer melt further comprises bismuth subcarbonate as a radio-opacifying agent.

27. The method of claim 26, comprising shaping said melt into a matrix polymer region of said implantable or insertable medical device by an extrusion process.

11. A method of manufacturing an implantable or insertable medical device comprising:

providing a combination of (a) one or more biocompatible matrix polymers and (b) bioactive agents comprising (i) an antimicrobial agent and (ii) a microbial attachment/biofilm synthesis inhibitor;

mixing said one or more biocompatible matrix polymers with said bioactive agents to a form a homogeneous mixture of said one or more matrix polymers and said bioactive agents under conditions that substantially prevent preferential partitioning of any of said bioactive agents to a surface of any of said biocompatible matrix polymers and that substantially prevent chemical reaction of said bioactive agents; and

shaping said homogeneous mixture into an annular matrix polymer region of said implantable or insertable medical device, wherein said shaping comprises co-extruding said annular matrix polymer region, a first polymeric barrier layer at least partially covering an interior surface of said annular matrix polymer region, and a second polymeric barrier layer at least partially covering an exterior surface of said annular matrix polymer region, wherein said annular matrix polymer region comprises an ethylene vinyl acetate copolymer having a vinyl acetate content of from about 19% to about 28% and said first and second polymeric barrier layers comprise a metallocene catalyzed polyethylene or polyethylene copolymer, or an ionomer.

12. The method of claim 11, wherein said annular matrix polymer region comprises salicylic acid or a salt thereof as said microbial attachment/biofilm synthesis inhibitor, triclosan as said antimicrobial agent and bismuth subcarbonate as a radio-opacifying agent;

and, said coextrusion is performed under conditions such that said salicylic acid or salt thereof does not preferentially partition to a surface of said first annular matrix polymer region or to a surface of said first or second polymeric barrier layers.

13. A method of manufacturing an implantable or insertable medical device comprising:

mixing a combination comprising (a) one or more biocompatible matrix polymers comprising an ethylene-vinyl acetate copolymer (b) additives comprising (i) an antimicrobial agent and (ii) salicylic acid by a process that comprises applying mechanical shear to said combination, and (c) bismuth subcarbonate as a radio-opacifying agent ; and

processing said combination under conditions that substantially prevent preferential partitioning of any of said bioactive agents to a surface of any of said biocompatible matrix polymers and that substantially prevent chemical reaction of said bioactive agents; and

shaping said mixture into a matrix polymer region of an implantable or insertable medical device.

14. The method of claim 13, wherein said antimicrobial agent comprises triclosan.

15. The method of claim 14, wherein said shaping comprises a process selected from molding, casting and extrusion.

16. The method of claim 15, wherein said extrusion comprises forming an annular matrix polymer region.

17. The method of claim 16, further comprising forming at least one polymeric barrier layer at least partially covering a surface of said annular matrix polymer region.

18. The method of claim 17, wherein said polymeric barrier layer comprises a metallocene catalyzed polyethylene or polyethylene copolymer, or an ionomers.

19. The method of claim 17, wherein said method comprises co extruding said polymeric barrier layer and said annular matrix polymer region.